Faculty Information

What We Do
Recent Publications



Dr. Peter R. Hull – M.B.B.Ch., M.Med. (Derm.), Ph.D., F.R.C.P.C. – Professor, Department Head
Dr. Duane J. Lichtenwald – B.Sc., M.D., F.R.C.P.C. – Clinical Associate Professor
Dr. Marius A. Roos – M.B.B.Ch., M.Med. (Derm.), F.C.Derm. (S.A.) – Clinical Associate Professor


Dr. Karen Holfeld – M.D., F.R.C.P.C. – Clinical Associate Professor
Dr. Roberta M. McKay – M.D., F.R.C.P.C. – Clinical Professor

What We Do

The Department of Dermatology is responsible for undergraduate medical teaching, residency training, and continuing medical education in dermatology at the University of Saskatchewan. Basic and clinically applied research in cutaneous science is an equally important mandate of the Department which serves as a resource for promoting excellence in patient care through its educational, research, and clinical activities.

Recent Publications from this Department

Hull PR. Results of the Canadian ApligrafTM (Graftskin) Post-Marketing Surveillance Program. Wounds. 2000; Sept/Oct; 12(5) Suppl A: 50A-57A.

Hull PR and Saxena A. Mycosis Fungoides and Chronic Lymphatic Leukemia - Composite T-Cell and B-Cell lymphomas Presenting in the Skin. Br J Dermatol. 2000; 143: 439-444.

Geldenhuys L, Radhi J, and Hull PR. Mycosis Fungoides and Cutaneous Hodgkin’s Disease in the Same Patient: A Case Report. J Cutan Path. 1999 Jul; 26(6): 311-4.

Schnell AH, Elston RC, Hull PR and Lane PR. Major Gene Segregation of Actinic Prurigo in North American Indians in Saskatchewan. Amer J Medical Genet. 2000; 92: 212-219.

Hull PR and Demkiw-Bartel C. Isotretinoin Use in Acne – A Prospective Evaluation of Adverse Events. Journal Cutaneous Medicine and Surgery. 2000; 4(2): 66-70.

Saxena A, Angel S, Geldenhuys L, Hull PR. A combination of abnormal immunoarchitecture and clonal B-cell population correctly identifies the biologic nature of cutaneous B-cell infiltrates. Amer J Clin Path, 1999; 112; 495-512.

Dolynchuk K, Hull PR, Guenther L et al. The role of Apligraf in the treatment of venous leg ulcers. Ostomy/Wound Management. 1999:45(1):34-43.

Hull PR, Gupta AK, Summerbell RC. Onychomycosis - An Evaluation of Three Sampling Methods. J Am Acad Dermatol. 1998; 39: 101S-1017.

Vismer H, Hull PR. Prevalence, Epidemiology and Geographical Distribution of Sporothrix Schenckii Infections in Gauteng, South Africa. Mycopathologia. 1997; 137: 137-43.

Hull PR, Vismer H. Terbinafine Use in Sporotrichosis - A Review. Reviews in Contemporary Pharmacotherapy. 1997; 8: 343-347.

Starfield M, Hennies H-C, Jung M, Jenkins T, Wienker TF, Hull PR, Spurdle A, Kuster W, Ramsay M, and Reis A. Localization of the Gene for Keratolytic Winter Erythema (KWE) to 8p22-p23 and Evidence for a Founder Effect in the South African Afrikaans speakers. Am J Hum Genet. 1997; 61: 370-378.

Gupta A, Sibbald G, Lynde C, Hull PR, Prussick R, Shear N, Daniel R, Elewski B. A Survey and Treatment of Onychomycosis in Children. J Am Acad Dermatol. 1997; 36: 395-402.

Hull PR. Relapse, Re-infection and Prevention of Onychomycosis. Dermatology. 1997; 194 (Suppl 1) 7-9.

Drake LA, Shear NH, Arlette JP, Cloutier R, Danby FW, Elewski B, GarnisJones S, Giroux JM, Gratton D, Gulliver W, Hull PR, et al. Oral Terbinafine (Lamisil) in the Treatment of Toenail Onychomycosis: North American Multicenter Study. J Am Acad Dermatol. 1997 Nov; 37(5 Pt 1): 740-745.